Evaluation of the TARGET score for MRI-based detection of prostate cancer recurrence in patients treated with HIFU hemiablation
The strength of the TARGET score was its high NPV, implying its potential to rule out cs-PCa. However, the moderate sensitivity and specificity, low PPV and moderate inter-reader agreement indicate a limited reliability of TARGET to consistently identify cs-PCa recurrence. The generalizability of these findings is restricted by the overall small sample size.
Authors
- Roman Ganzer (ORCID: https://orcid.org/0000-0002-4590-5749)
- Sebastian Ebel (ORCID: https://orcid.org/0000-0001-6856-6455)
- Nilüfer Deniz Alberalar (ORCID: https://orcid.org/0000-0002-1734-7145)
- Alexander Schaudinn
- Lars‐Christian Horn (ORCID: https://orcid.org/0000-0002-9775-4858)
- Boris Hadaschik (ORCID: https://orcid.org/0000-0002-1052-2692)
- Constantin Ehrengut
- Andreas Blana
- Toni Franz
- Jens‐Uwe Stolzenburg
- H Schlemmer
- Timm°Denecke (ORCID: https://orcid.org/0000-0003-3313-3208)
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Leipzig (DE)
- Klinikum Fürth (DE)
- Asklepios (DE)
- Leipzig University (DE)
Publication Details
- Journal
- European Journal of Radiology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1016/j.ejrad.2025.112572
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00